Unilateral Subacromial Impingement Syndrome.
Conditions
Interventions
Intervention 1: Intervention group: HIL group: HIL will be applied using the Delta Laser New Age device (Italy) with a wavelength of 980 nm and 13 W maximum power output with probe diameter of 1 cm. T
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Aged 18-55 years Positive Neer and Hawkins tests in involved side Positive Empty can and Speed tests in involved side Painful range of motion active and passive abduction, flexion, internal rotation and external rotation of involved shoulder At least 4 weeks have passed since the onset of pain and symptoms on the involved side Resting pain score above 3 in the subacromial region of the involved side Confirmation of diagnosis of phase 1 and 2 subacromial impingement syndrome based on Neer criteria in MRI findings
Exclusion criteria
Exclusion criteria: Radicular pain in involved upper limb Glenohumeral and acromioclavicular joint osteoarthritis History of shoulder surgeries history of acute trauma to the shoulder girdle History of humerus head fractures on the involved shoulder Frozen shoulder Thyroid diseases Heart disease and pacemaker Pregnancy Skin complications in the treated area Tumor Active cancer or a history of cancer less than one year after treatment Epilepsy Photosensitive diseases Mental illness Systemic and metabolic diseases Diabetes Presence of calcium deposition, complete or incomplete rupture in rotator cuff tendons and long head of biceps Fibromyalgia Physiotherapy or drug injections to reduce pain in the subacromial area at the same time as the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain at rest. Timepoint: Prior to treatment initiation, at the end of the 10 treatment sessions and 1month after the completion of last treatment session. Method of measurement: Visual Analog Scale.;Pain while moving. Timepoint: Prior to treatment initiation, at the end of the 10 treatment sessions and 1month after the completion of last treatment session. Method of measurement: Visual Analog Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Shoulder active flexion range of motion. Timepoint: Prior to treatment initiation, at the end of the 10 treatment sessions and 1month after the completion of last treatment session. Method of measurement: Standard plastic goniometer.;Shoulder active abduction range of motion. Timepoint: Prior to treatment initiation, at the end of the 10 treatment sessions and 1month after the completion of last treatment session. Method of measurement: Standard plastic goniometer.;Shoulder active external rotation range of motion. Timepoint: Prior to treatment initiation, at the end of the 10 treatment sessions and 1month after the completion of last treatment session. Method of measurement: Standard plastic goniometer.;Shoulder active internal rotation range of motion. Timepoint: Prior to treatment initiation, at the end of the 10 treatment sessions and 1month after the completion of last treatment session. Method of measurement: Standard plastic goniometer.;Shoulder passive flexion range of motion. Timepoint: Prior to treatment initiation, at the end of the 10 treatment sessions and 1month after the completion of last treatment session. Method of measurement: Standard plastic goniometer.;Shoulder passive abduction range of motion. Timepoint: Prior to treatment initiation, at the end of the 10 treatment sessions and 1month after the completion of last treatment session. Method of measurement: Standard plastic goniometer.;Shoulder passive external rotation range of motion. Timepoint: Prior to treatment initiation, at the end of the 10 treatment sessions and 1month after the completion of last treatment session. Method of measurement: Standard plastic goniometer.;Shoulder passive internal rotation range of motion. Timepoint: Prior to treatment initiation, at the end of the 10 treatment sessions and 1month after the completion of last treatment session. Method of measurement: Standard plastic goniometer.;Hand grip. Timepoint: Prior to treatment initiation, at the end of the 10 treatm | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactPardis Norouzi
Babol University of Medical Sciences
Outcome results
None listed